EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nephros's enterprise value is $19.67 Mil.
Nephros's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $14.24 Mil. Therefore, Nephros's EV-to-Revenue for today is 1.38.
The historical rank and industry rank for Nephros's EV-to-Revenue or its related term are showing as below:
NEPH'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.7 Med: 6.64 Max: 18.91
Current: 1.38
During the past 13 years, the highest EV-to-Revenue of Nephros was 18.91. The lowest was 0.70. And the median was 6.64.
NEPH's EV-to-Revenue is ranked better than 74.46% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: 3.265
vs NEPH: 1.38
As of today (2024-05-12), Nephros's stock price is $2.10.
Nephros's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.37. Therefore, Nephros's PS Ratio for today is 1.53.
Nephros EV-to-Revenue Historical Data
The historical data trend for Nephros's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nephros's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephros's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nephros's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Nephros's EV-to-Revenue falls into.
Nephros's current Enterprise Value is $19.67 Mil.
Nephros's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephros's share price for today is $2.10.
Nephros's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.37.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephros EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Nephros's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Nephros Inc is a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, it sell water filtration products and waterborne pathogen detection products. In commercial markets, the company manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The operating segments of the group are Water Filtration, Pathogen Detection and Renal Products of which key revenue is derived from Water Filtration segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEPH has been successfully added to your 